Cite
HARVARD Citation
Fridkis-Hareli, M. et al. (n.d.). The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models. Molecular immunology. pp. 150-164. [Online].